Second generation meningococcal OMP-LPS vaccines.
Poolman
J T
JT
Unit for Bacterial Vaccine Development and Pathogenesis Research, National Institute for Public Health and Environmental Protection, Bilthoven, The Netherlands.
van der Ley
P A
PA
Wiertz
E J
EJ
Hoogerhout
P
P
D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000145:classification / Q000276:immunology*; D001428:Bacterial Vaccines / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D004251:DNA Transposable Elements; D000939:Epitopes; D006801:Humans; D008070:Lipopolysaccharides / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D022401:Meningococcal Vaccines; D009844:Oligosaccharides; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D014170:Transformation, Genetic
D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D004251:DNA Transposable Elements; D000939:Epitopes; D008070:Lipopolysaccharides; D022401:Meningococcal Vaccines; D009844:Oligosaccharides; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B